Defense Secretary Returns to Hospital With Bladder Issues

• Robin Foster HealthDay Reporter
• February 12, 2024
• Full Page

MONDAY, Feb. 12, 2024 (Healthday News) -- Defense Secretary Lloyd Austin III, who spent time in intensive care last month for complications related to prostate cancer surgery performed in December, has returned to the hospital with bladder issues, the Pentagon announced Sunday...

Defense Secretary Has 'Excellent' Prognosis After Prostate Cancer Treatment, Docs Say

• Robin Foster HealthDay Reporter
• January 29, 2024
• Full Page

Defense Secretary Lloyd Austin will not need any more treatment for his prostate cancer and his prognosis is "excellent," his doctors say.

The news came after a follow-up appointment Austin had at Walter Reed National Military Center on Friday.

“Beyond planned ph...

Defense Secretary Austin Leaves Hospital After Prostate Cancer Surgery Complications

• Robin Foster HealthDay Reporter
• January 16, 2024
• Full Page

Following two weeks of hospital care for complications from prostate cancer surgery, U.S. Defense Secretary Lloyd Austin has been released from Walter Reed National Military M...

Prostatitis: What It Is, Symptoms, Causes & Treatment

• Ann Schreiber HealthDay Reporter
• May 31, 2023
• Full Page

When most men think about their prostate, it's to worry about whether they have prostate cancer or not. But another condition is far more common and plenty painful.

Prostatitis involves inflammation of the prostate gland and sometimes the areas around it. Not only is pro...

Need a Prostate Exam? Here's What to Expect

• Ann Schreiber HealthDay Reporter
• May 31, 2023
• Full Page

You're due for a prostate exam, but you don't know what to expect.

So, what is this exam like?

Regular check-ups are essential for maintaining your health, and a prostate exam is crucial to preventive care for men. Not only is it a screening test f...

Most Men With Low-Risk Prostate Cancers Now Forgo Immediate Surgery

• Alan Mozes HealthDay Reporter
• April 4, 2023
• Full Page

Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates.

Instead, many U.S. men with low- or intermediate-risk prostate cancer have embraced “active s...

Medication Shortage Means Many With Advanced Prostate Cancer Are Missing Treatments

• Cara Murez HealthDay Reporter
• March 21, 2023
• Full Page

An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment.

The drug's maker, Novartis Pharmaceuticals Corp., has said it can't keep up with demand for the medication, known as Pluv...

Embolization Treatment Could Offer Drug-Free Relief From Enlarged Prostate

• Dennis Thompson HealthDay Reporter
• March 2, 2023
• Full Page

Men suffering from an enlarged prostate can receive long-term relief from a minimally invasive procedure that partially blocks blood flow to the gland, new research reports.

The procedure, called prostate artery embolization (PAE), dramatically improved urinary symptoms...

Black Men Get Better Outcomes From Radiation Rx for Prostate Cancer

• Denise Mann HealthDay Reporter
• January 3, 2022
• Full Page

A new analysis uncovers a racial paradox in prostate cancer care: While Black men are often diagnosed later and with more aggressive disease than white men, radiation therapy seems to work better for them than for their white peers.

To come to that conclusion, resea...

Black Men Less Likely to Get Follow-Up MRI When Test Suggests Prostate Cancer

• Robert Preidt
• November 10, 2021
• Full Page

Black, Hispanic and Asian men in the United States are less likely than white men to receive a follow-up MRI after a screening suggests prostate cancer, a new study finds.

"We can't say definitively if the reason Black, Hispanic, and Asian men did not receive this partic...

Urine Test May Spot Aggressive Prostate Cancer

• Steven Reinberg HealthDay Reporter
• November 4, 2021
• Full Page

A urine test might one day be able to tell which prostate cancer patients need immediate treatment and which don't, British researchers report.

"Prostate cancer can be divided into low and high risk -- the low-risk men rarely require treatment, and the high-risk cer...

Shorter Course of Post-Op Radiation May Work Well for Prostate Cancer Patients

• Amy Norton HealthDay Reporter
• October 27, 2021
• Full Page

After prostate cancer surgery, men can safely undergo fewer radiation treatments at higher doses, a new clinical trial shows.

Researchers found that the shorter regimen -- given over five weeks, instead of seven -- did not raise patients' odds of lasting side effects.

Enlarged Prostate Doesn't Raise a Man's Odds for Cancer: Study

• Steven Reinberg HealthDay Reporter
• August 25, 2021
• Full Page

Does having an enlarged prostate doom you to prostate cancer?

Far from it, a new study suggests.

Also called benign prostatic hyperplasia (BPH), the condition may actually provide some protection for men from developing prostate cancer, researchers report.

"M...

Mediterranean Diet Could Help Stop Prostate Cancer's Spread

• Ernie Mundell
• January 8, 2021
• Full Page

Food as medicine: New research suggests that a healthy Mediterranean diet might lower the risk of prostate cancer progressing to a more advanced state.

The relative lack of saturated fat in these diets might be a major reason why.

The Mediterranean diet is "known f...

Radiation Rx for Prostate Cancer Can Cause Financial Pain: Study

• Cara Murez
• December 4, 2020
• Full Page

People diagnosed with cancer often have many concerns, including "financial toxicity," the hardship and stress associated with the cost of treatment.

New research found that for men with early-stage prostate cancer, choices about initial treatments can be a source of str...

'Hidden' Prostate Cancer on Biopsy Usually Means Good Outcome: Study

• Robert Preidt
• November 23, 2020
• Full Page

Negative biopsies among early-stage prostate cancer patients who've chosen active surveillance are associated with a low risk of disease progression, but they aren't a sign that their cancer has completely vanished, a new study indicates.

Active surveillance refers to cl...

'Watchful Waiting' OK for Black Men With Prostate Cancer

• Robert Preidt
• November 6, 2020
• Full Page

A 'watchful waiting' approach to care may be safe for Black Americans with low-risk prostate cancer, a new study suggests.

Black patients are less likely than whites to be offered watchful waiting, also called active surveillance. This may be because compared to whites, ...

More Prostate Cancers Are Being Diagnosed at a Later Stage

• Steven Reinberg
• October 16, 2020
• Full Page

While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the same analysis finds that the opposite is true for advanced prostate cancer cases.

In fact, the number of cases of cancer tha...

With PSA Test Out of Favor, Cases of Advanced Prostate Cancer Are Rising

• Serena Gordon
• May 20, 2020
• Full Page

Prostate cancer screening guidelines have been evolving for more than a decade, but new research suggests that recommendations against routine prostate cancer testing may have come at a steep price -- more men getting diagnosed with advanced prostate cancers.

The st...

'Watchful Waiting' Less Likely for Black Prostate Cancer Patients

• Robert Preidt
• May 22, 2019
• Full Page

"Watchful waiting" is on the rise overall among U.S. men with low-risk prostate cancer, but black men remain less likely to opt for it, a new study finds.

For the study, researchers examined 2010-2015 data on more than 50,000 low-risk prostate cancer patients in the ...

Use of Meds for Enlarged Prostate Might Delay a Cancer Diagnosis

• E.J. Mundell
• May 6, 2019
• Full Page

Men who take medicines for an enlarged prostate can have years-long delays in their diagnosis of prostate cancer and more advanced prostate cancer when they're diagnosed, a new study finds.

The reason? Drugs in this class -- such as Proscar (finasteride) and Avodart ...